WHO ICTRP trial
Prospective, randomized, open-label, clinical trial evaluating the effects of…
JPRN-UMIN000011752 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000011752 |
|---|---|
| Public title | Prospective, randomized, open-label, clinical trial evaluating the effects of dipeptidyl peptidase-4 (DPP4) inhibitors on progression of atherosclerotic plaques and endothelial function in type 2 diabetic patients |
| Scientific title | Prospective, randomized, open-label, clinical trial evaluating the effects of dipeptidyl peptidase-4 (DPP4) inhibitors on progression of atherosclerotic plaques and endothelial function in type 2 diabetic patients - Clinical trial evaluating the effects of dipeptidyl peptidase-4 (DPP4) inhibitors |
| Primary sponsor | National Defense Medical College |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | type 2 diabetes |
| Interventions | Treatment for type 2 diabetes with DPP4 inhibitors Treatment for type 2 diabetes without DPP4 inhibitors |
| Registration date | Sep 14, 2013 |
| Target size | 66 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: